2006). Questionnaires

were completed within 3 months of magnetic resonance imaging (MRI) scan in the patient sample (median time span = same day; range, 0–69 days). Socioemotional self-awareness To obtain an index of subjects’ socioemotional self-awareness, we generated discrepancy scores by subtracting the informant’s rating of the subject’s current empathic {TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor|TNF alpha inhibitor|TNF-alpha inhibitor| buy TNF-alpha inhibitor|TNF-alpha inhibitor ic50|TNF-alpha inhibitor price|TNF-alpha inhibitor cost|TNF-alpha inhibitor solubility dmso|TNF-alpha inhibitor purchase|TNF-alpha inhibitor manufacturer|TNF-alpha inhibitor research buy|TNF-alpha inhibitor order|TNF-alpha inhibitor mouse|TNF-alpha inhibitor chemical structure|TNF-alpha inhibitor mw|TNF-alpha inhibitor molecular weight|TNF-alpha inhibitor datasheet|TNF-alpha inhibitor supplier|TNF-alpha inhibitor in vitro|TNF-alpha inhibitor cell line|TNF-alpha inhibitor concentration|TNF-alpha inhibitor nmr|TNF-alpha inhibitor in vivo|TNF-alpha inhibitor clinical trial|TNF-alpha inhibitors|TNF-alpha signaling inhibitor|TNF-alpha pathway inhibitor|TNF-alpha signaling pathway inhibitor|TNF-alpha signaling inhibitors|TNF alpha pathway inhibitors|TNF-alpha signaling pathway inhibitors|TNF-alpha inhibitor library|TNF-alpha activity inhibition|TNF-alpha activity|TNF-alpha inhibition|TNF-alpha inhibitors library|TNF alpha inhibitor libraries|TNF-alpha inhibitor screening library|TNF-alpha high throughput screening|TNF-alpha inhibitors high throughput screening|TNF-alpha phosphorylation|TNF-alpha screening|TNF-alpha assay|TNF-alpha animal study| concern (considered the most accurate rating) from the subject’s self-rating of his/her current empathic concern. Thus, scores close to zero indicated that the subject’s Inhibitors,research,lifescience,medical self-awareness was accurate, while scores farther from zero suggested greater inaccuracy. The directionality of the discrepancy score indicated whether subjects overestimated (positive value) or underestimated (negative value) their level of empathic concern relative to the informants’ rating. To avoid spurious brain–behavior correlations due to extreme discrepancy scores, we converted discrepancy scores to z-scores based on subjects’ mean and standard Inhibitors,research,lifescience,medical deviation (SD) and checked for z-scores above +3 SDs and

below −3 SDs, though none were found and no subject was excluded on this basis. Change in empathic concern Inhibitors,research,lifescience,medical Some subjects in the study were expected to have undergone significant changes (typically decreases) in their level of empathic concern in the past 5–10 years due to neurologic disease. Such changes may have directly influenced the accuracy

of subjects’ self-description of the trait (Clare 2004a). To account for this potentially confounding effect, change in empathic concern score was generated by subtracting the informant’s rating of the subject’s current empathic concern from the informant’s rating of the subject’s Inhibitors,research,lifescience,medical premorbid empathic concern. This score was included as a covariate in the VBM analysis removing potential confounds. Separation into polisher/neutral Inhibitors,research,lifescience,medical and tarnisher/neutral subsamples The sample was separated into polisher/neutral and tarnisher/neutral subsamples based on value and directionality of the subjects’ discrepancy scores. Subjects with discrepancy scores above the mean − ½ SD were part of the polisher/neutral sample (n = 69). Subjects with discrepancy scores below the mean + ½ SD were part of the tarnisher/neutral isothipendyl sample (n = 72). Consequently, subjects with discrepancy scores close to the mean (“neutrals”) were part of both groups. “Neutrals” were included in both groups to retain the naturally occurring variability in discrepancy scores and gray matter volumes in the statistical parametric mapping (SPM) group analyses, increasing power to detect neural substrates of over—and underestimation of one’s empathic concern across the whole brain. Notably, all seven diagnostic groups included “neutrals,” suggesting high variability in gray matter volumes within the “neutrals.